Plasma rich in growth factors promotes bone tissue regeneration by stimulating proliferation, migration, and autocrine secretion in primary human osteoblasts

Journal of Periodontology

Volumn 84, Issue 8, 2013, Pages 1180-1190

  Anitua, Eduardo ^a,b   Tejero, Ricardo ^a   Zalduendo, Mari Mar ^a   Orive, Gorka ^a  

^a Biotechnology Institute   (Spain)

^b Foundation Eduardo Anitua   (Spain)

Author keywords

Blood platelets; Bone and bones; Intercellular signaling peptides and proteins; Osteoblasts; Platelet rich plasma; Regeneration

Indexed keywords

ALKALINE PHOSPHATASE; COLLAGEN TYPE 1; ENDOTHELIAL CELL GROWTH FACTOR; HGF PROTEIN, HUMAN; OSTEOCALCIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR A; SCATTER FACTOR; SIGNAL PEPTIDE; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; BONE REGENERATION; CELL CULTURE; CELL MOTION; CELL PROLIFERATION; CHEMOTAXIS; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; FEMALE; HUMAN; JAW; MALE; MIDDLE AGED; OSTEOBLAST; PLASMA; THROMBOCYTE RICH PLASMA; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ALKALINE PHOSPHATASE; ALVEOLAR PROCESS; AUTOCRINE COMMUNICATION; BONE REGENERATION; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOTAXIS; COLLAGEN TYPE I; ENDOTHELIAL GROWTH FACTORS; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; OSTEOBLASTS; OSTEOCALCIN; PLASMA; PLATELET-DERIVED GROWTH FACTOR; PLATELET-RICH PLASMA; PROTO-ONCOGENE PROTEINS C-SIS; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84882239726     PISSN: 00223492     EISSN: None     Source Type: Journal    
DOI: 10.1902/jop.2012.120292     Document Type: Article

References (49)

1. Bunta AD. It is time for everyone to own the bone. Osteoporos Int 2011;22 (Suppl. 3):477-482.
2. Esposito M, Grusovin MG, Coulthard P, Worthington HV. The efficacy of various bone augmentation procedures for dental implants: A Cochrane systematic review of randomized controlled clinical trials. Int J Oral Maxillofac Implants 2006;21:696-710.
3. Ahlmann E, Patzakis M, Roidis N, Shepherd L, Holtom P. Comparison of anterior and posterior iliac crest bone grafts in terms of harvest-site morbidity and functional outcomes. J Bone Joint Surg Am 2002;84-A:716-720.
4. Tare RS, Kanczler J, Aarvold A, Jones AM, Dunlop DG, Oreffo RO. Skeletal stem cells and bone regeneration: Translational strategies from bench to clinic. Proc Inst Mech Eng H 2010;224:1455-1470.
5. Kwan MD, Slater BJ, Wan DC, Longaker MT. Cellbased therapies for skeletal regenerative medicine. Hum Mol Genet 2008;17 (R1):R93-R98.
6. Lieberman JR, Daluiski A, Einhorn TA. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 2002; 84-A:1032-1044.
7. Panetta NJ, Gupta DM, Longaker MT. Bone regeneration and repair. Curr Stem Cell Res Ther 2010;5: 122-128.
8. Mayr-Wohlfart U, Waltenberger J, Hausser H, et al. Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. Bone 2002;30:472-477.
9. Verrier S, Meury TR, Kupcsik L, Heini P, Stoll T, Alini M. Platelet-released supernatant induces osteoblastic differentiation of human mesenchymal stem cells: Potential role of BMP-2. Eur Cell Mater 2010; 20:403-414.
10. Woo EJ. Adverse events reported after the use of recombinant human bone morphogenetic protein 2. J Oral Maxillofac Surg 2012;70:765-767.
11. Chen FM, Zhang M, Wu ZF. Toward delivery of multiple growth factors in tissue engineering. Biomaterials 2010;31:6279-6308.
12. Chen FM, Zhang J, Zhang M, An Y, Chen F, Wu ZF. A review on endogenous regenerative technology in periodontal regenerative medicine. Biomaterials 2010;31:7892-7927.
13. Anitua E, Sánchez M, Orive G, Andia I. Delivering growth factors for therapeutics. Trends Pharmacol Sci 2008;29:37-41.
14. Anitua E, Alkhraisat MH, Orive G. Perspectives and challenges in regenerative medicine using plasma rich in growth factors. J Control Release 2012;157:29-38.
15. Anitua E, Sanchez M, Nurden AT, et al. Autologous fibrin matrices: A potential source of biological mediators that modulate tendon cell activities. J Biomed Mater Res A 2006;77:285-293.
16. Anitua E, Troya M, Orive G. Plasma rich in growth factors promote gingival tissue regeneration by stimulating fibroblast proliferation and migration and by blocking transforming growth factor-b1-induced myodifferentiation. J Periodontol 2012;83:1028-1037.
17. Anitua E, Sánchez M, Prado R, Orive G. Plasma rich in growth factors: The pioneering autologous technology for tissue regeneration. J Biomed Mater Res A 2011;97:536.
18. Graziani F, Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M. The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 2006;17:212-219.
19. Anitua E, Sánchez M, Orive G. Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Deliv Rev 2010;62:741-752.
20. Anitua E, Sánchez M, Orive G, Andía I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 2007;28:4551-4560.
21. Anitua E, Orive G, Aguirre JJ, Ardanza B, Andía I. 5-year clinical experience with BTI dental implants: Risk factors for implant failure. J Clin Periodontol 2008;35:724-732.
22. Anitua E, Aguirre JJ, Algorta J, et al. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater 2008;84:415-421.
23. Sánchez M, Anitua E, Azofra J, Andía I, Padilla S, Mujika I. Comparison of surgically repaired Achilles tendon tears using platelet-rich fibrin matrices. Am J Sports Med 2007;35:245-251.
24. Hughes FJ, Aubin JE, Heersche JN. Differential chemotactic responses of different populations of fetal rat calvaria cells to platelet-derived growth factor and transforming growth factor beta. Bone Miner 1992;19:63-74.
25. Lind M, Deleuran B, Thestrup-Pedersen K, Søballe K, Eriksen EF, Bünger C. Chemotaxis of human osteoblasts. Effects of osteotropic growth factors. APMIS 1995;103:140-146.
26. Lind M, Eriksen EF, Bünger C. Bone morphogenetic protein-2 but not bone morphogenetic protein-4 and -6 stimulates chemotactic migration of human osteoblasts, human marrow osteoblasts, and U2-OS cells. Bone 1996;18:53-57.
27. Fiedler J, Brill C, BlumWF, Brenner RE. IGF-I and IGF-II stimulate directed cell migration of bone-marrowderived human mesenchymal progenitor cells. Biochem Biophys Res Commun 2006;345:1177-1183.
28. Gruber R, Varga F, Fischer MB, Watzek G. Platelets stimulate proliferation of bone cells: Involvement of platelet-derived growth factor, microparticles and membranes. Clin Oral Implants Res 2002;13:529-535.
29. Gruber R, Karreth F, Frommlet F, Fischer MB, Watzek G. Platelets are mitogenic for periosteumderived cells. J Orthop Res 2003;21:941-948.
30. Lucarelli E, Beccheroni A, Donati D, et al. Plateletderived growth factors enhance proliferation of human stromal stem cells. Biomaterials 2003;24:3095-3100.
31. Uggeri J, Belletti S, Guizzardi S, et al. Dose-dependent effects of platelet gel releasate on activities of human osteoblasts. J Periodontol 2007;78:1985-1991.
32. Kells AF, Coats SR, Schwartz HS, Hoover RL. TGF-beta and PDGF act synergistically in affecting the growth of human osteoblast-enriched cultures. Connect Tissue Res 1995;31:117-124.
33. Arisato T, Hashiguchi T, Sarker KP, et al. Highly accumulated platelet vascular endothelial growth factor in coagulant thrombotic region. J Thromb Haemost 2003;1:2589-2593.
34. Rendu F, Brohard-Bohn B. The platelet release reaction: Granules' constituents, secretion and functions. Platelets 2001;12:261-273.
35. Madeddu P. Therapeutic angiogenesis and vasculogenesis for tissue regeneration. Exp Physiol 2005; 90:315-326.
36. Bussolino F, Di Renzo MF, Ziche M, et al. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992;119:629-641.
37. Tammela T, Enholm B, Alitalo K, Paavonen K. The biology of vascular endothelial growth factors. Cardiovasc Res 2005;65:550-563.
38. Grano M, Galimi F, Zambonin G, et al. Hepatocyte growth factor is a coupling factor for osteoclasts and osteoblasts in vitro. Proc Natl Acad Sci USA 1996; 93:7644-7648.
39. Lepperdinger G. Inflammation and mesenchymal stem cell aging. Curr Opin Immunol 2011;23:518-524.
40. Sanjabi S, Zenewicz LA, Kamanaka M, Flavell RA. Anti-inflammatory and pro-inflammatory roles of TGF-beta, IL-10, and IL-22 in immunity and autoimmunity. Curr Opin Pharmacol 2009;9:447-453.
41. Tojima H, Kakizaki S, Kosone T, et al. Hepatocyte growth factor overexpression ameliorates liver inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis. Hepatol Int 2012;6:620-630.
42. Bendinelli P, Matteucci E, Dogliotti G, et al. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: Mechanisms of NFkB inhibition via HGF. J Cell Physiol 2010;225: 757-766.
43. de Gonzalo-Calvo D, Neitzert K, Fernández M, et al. Differential inflammatory responses in aging and disease: TNF-alpha and IL-6 as possible biomarkers. Free Radic Biol Med 2010;49:733-737.
44. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008;214:199-210.
45. Hardy R, Cooper MS. Bone loss in inflammatory disorders. J Endocrinol 2009;201:309-320.
46. Lu HH, Vo JM, Chin HS, et al. Controlled delivery of platelet-rich plasma-derived growth factors for bone formation. J Biomed Mater Res A 2008;86:1128-1136.
47. Lin SS, Landesberg R, Chin HS, Lin J, Eisig SB, Lu HH. Controlled release of PRP-derived growth factors promotes osteogenic differentiation of human mesenchymal stem cells. Conf Proc IEEE Eng Med Biol Soc 2006;1:4358-4361.
48. Mann S. Biomineralization: Principles and Concepts in Bioinorganic Materials Chemistry. Oxford, U.K.: Oxford University Press. 2001; pp 89-124.
49. Jayakumar P, Di Silvio L. Osteoblasts in bone tissue engineering. Proc Inst Mech Eng H 2010;224:1415-1440.